To reduce the risk of hyperkalemia, aldosterone antagonists should generally be given only to patients whose potassium level is < 5.0 mEq / L (< 5 mmol / L), serum creatinine is < 2.5 mg / dL (< 221 micromol / L), and GFR is > 30 mL / min/1.73 m 2.